Match each of the following sets of serum biochemical findings (calcium, phosphorus, and intact parathyroid hormone) with the diagnostic entity it most characteristically represents.
(Reference ranges: Serum calcium 8.4-10.2 mg/dL, Serum phosphorus 2.5-4.5 mg/dL, Intact PTH 15-65 pg/mL)
- Calcium 11.5 mg/dL, Phosphorus 2.2 mg/dL, Intact PTH 95 pg/mLPrimary hyperparathyroidism
- Calcium 12.8 mg/dL, Phosphorus 2.4 mg/dL, Intact PTH 5 pg/mLHypercalcemia of malignancy
- Calcium 7.6 mg/dL, Phosphorus 5.8 mg/dL, Intact PTH 150 pg/mLChronic kidney disease
- Calcium 8.1 mg/dL, Phosphorus 2.1 mg/dL, Intact PTH 135 pg/mLVitamin D deficiency
Cevap
Profile 1 matches Primary hyperparathyroidism, Profile 2 matches Hypercalcemia of malignancy, Profile 3 matches Chronic kidney disease, and Profile 4 matches Vitamin D deficiency.
Each laboratory profile distinctly reflects the underlying pathophysiology of a specific calcium disorder. Primary hyperparathyroidism is characterized by autonomous PTH secretion leading to high calcium and low phosphorus. In hypercalcemia of malignancy, calcium is elevated via alternative pathways (like PTHrP or bone metastases), which strongly suppresses endogenous PTH. Chronic kidney disease results in phosphate retention and impaired calcitriol synthesis, causing low calcium, high phosphorus, and high PTH. Vitamin D deficiency results in poor intestinal absorption of both calcium and phosphorus; the subsequent secondary hyperparathyroidism normalizes or attempts to normalize calcium but further lowers phosphorus via renal wasting.
Adım Adım Çözüm
Anahtar Kavram
Interpreting calcium, phosphorus, and parathyroid hormone levels together to differentiate the underlying etiologies of calcium homeostasis disorders.